Albany Molecular Research, Inc. (AMRI), a global provider of contract research, development and manufacturing services, expanded access to its accelerated solutions platform, spanning R&D to manufacturing for orphan and rare disease products. The company made targeted investments globally to expand its scale and compound handling capabilities and made additions to the teams that address the specific needs of these complex products in its facilities in Albany, NY, Grafton, WI, and Glasgow, Sc...